What You Should Know:
- Philips and BioIntelliSense has been selected by the
U.S. Army Medical Research and Development Command (USAMRDC) to receive nearly $2.8M
from the U.S. Department of Defense (DoD) to validate BioIntelliSense’s
FDA-cleared BioSticker device for the early detection of COVID-19 symptoms.
- Working with the University of Colorado Anschutz
Medical Campus, the clinical study will consist of 2,500 eligible participants
with a recent, known COVID-19 exposure and/or a
Read More
COVID-19 Exposed The True Vulnerability of Healthcare Infrastructure
Martyn Crew, Director of Solutions Marketing at Gigamon
In 2019, 41 million patient records breached in 572 reported incidents at an average cost of $1.8 million per breach. These statistics are far from surprising with healthcare records selling for a reported average of $45 on the dark web. Unfortunately, the year 2020 aggravated these issues as COVID-19 exposed the true vulnerability of the healthcare infrastructure. Organizations not only had to manage the medical and financial impacts of
Read More
17 Recently Launched COVID-19 Vaccine Management Solutions to Know
An in-depth look at twelve recently released COVID-19 vaccine management solutions as COVID-19 vaccines are being distributed nationwide.
1. Microsoft
Microsoft
launches a COVID-19 vaccine management platform with partners Accenture and
Avanade, EY, and Mazik Global to help government and healthcare customers
provide fair and equitable vaccine distribution, administration, and monitoring
of vaccine delivery.
Microsoft Consulting Services (MCS) has deployed over 230 emergency COVID-19
Read More
Why Some COVID-19 Testing Protocols Aren’t What You Think
Pawel Czech, Founder of Nex.D
While countries around the world continue to flounder with regards to COVID-19 testing, everyone is wondering how national governments could get things so horribly wrong. It’s true that governments have acted incompetently, leaders can make poor judgment calls, and optimistic testing targets are rarely achieved.
But the claims of various ambitious big pharma companies—about their ability to deliver on capacity and accuracy alike—have created a smokescreen for
Read More
Vaccine Safety Expert Shares 5 COVID-19 Vaccine Facts to Protect 2021
Dr. Noam Tau of Sheba Medical Center
Now more than ever, public confidence is key. It's our job as medical professionals, the FDA's job, and public figures' job to convince the population to vaccinate by presenting the real results of studies.
The current vaccine hesitancy, which might result in a large proportion of people refusing vaccination, will leave us with an ongoing global crisis, even with the best vaccines ever made. A vaccine only works if it is actually administered.
Five
Read More
AI Algorithms Can Predict Outcomes of COVID-19 Patients with Mild Symptoms in ER
What You Should Know:
- Artificial intelligence algorithms can predict outcomes
of COVID-19 patients with mild symptoms in emergency rooms, according to recent
research findings published in Radiology: Artificial Intelligence journal.
- Researchers trained the algorithm from data on 338
positive COVID-19 patients between the ages of 21 and 50 by using diverse
patient data from emergency departments within Mount Sinai Health System
hospitals (The Mount Sinai Hospital in Manhattan, Mount
Read More
How Hackers Are Targeting COVID-19 Vaccine Distribution Chains – Q/A
With the US and other major countries poised to begin national
distribution of multiple FDA-approved COVID-19 vaccines, the cybersecurity threats
to secure COVID19
vaccine distribution is imminent. Earlier this month, IBM released a report on malicious cyber actors targeting
the COVID-19 cold chain—an integral part of delivering and storing a vaccine at
safe temperatures.
Impersonating a biomedical company, cyber actors are sending phishing and spear-phishing emails to executives and global
Read More
FDA Authorizes First Fully Over the Counter COVID-19 Home Test
What You Should Know:
- FDA grants Emergency Use Authorization for Ellume
COVID-19 Home Test for non-prescription home use in symptomatic and
asymptomatic individuals
- The first fully over-the-counter COVID-19 Home Test
demonstrated 96% accuracy in a multi-site US clinical study of both adults and
children 2 years and above
- Ellume is ramping up manufacture, with production on
track for over 100,000 tests per day in January 2021
Ellume, a
digital diagnostics announced its rapid,
Read More
Abbott Receives CE Mark for its COVID-19 IgG Quantitative Antibody Blood Test
What You Should Know:
- Abbott Receives CE Mark for its COVID-19 IgG Quantitative Antibody Blood Test that specifically detects levels of IgG antibodies that attach to the virus’ spike protein, which can be helpful to evaluate a person's immune response to vaccines.
- Abbott plans to submit its test for the U.S. Food and Drug Administration (FDA) emergency use authorization soon.
Abbott, today
announced it received CE Mark for its new quantitative SARS-CoV-2 IgG
(Immunoglobulin
Read More
Gleaning Insights for COVID-19: Why Claims and Clinical Data Matter
Emad Rizk, M.D., President, CEO & Chairman of the Board, Cotiviti
Healthcare organizations continue to rely heavily on data analytics to try to improve COVID-19 outcomes and public health. Since the novel coronavirus became widespread in the U.S., healthcare data scientists have leveraged clinical and claims data to pinpoint which underlying conditions put patients at higher risk of complications from COVID-19. Health systems are mining clinical data to predict surges in COVID-19 cases
Read More
